These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38015827)

  • 1. What do Hyperhidrosis Quality of Life Index (HidroQoL©) scores mean? Transferring science into practice by establishing a score banding system.
    Donhauser T; Gabes M; Özkan E; Masur C; Kamudoni P; Salek S; Abels C; Apfelbacher C
    Br J Dermatol; 2024 Mar; 190(4):519-526. PubMed ID: 38015827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhidrosis Quality of Life Index (HidroQoL©): further validation and clinical application in patients with axillary hyperhidrosis using data from a phase III randomized controlled trial.
    Gabes M; Jourdan C; Schramm K; Masur C; Abels C; Kamudoni P; Salek S; Apfelbacher C
    Br J Dermatol; 2021 Mar; 184(3):473-481. PubMed ID: 32510573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal validity of the Hyperhidrosis Quality of Life Index (HidroQoL©) in a phase IIIb clinical trial population with hyperhidrosis: responsiveness and meaningful change.
    Donhauser T; Gabes M; Masur C; Kamudoni P; Salek S; Abels C; Apfelbacher C
    Br J Dermatol; 2024 Oct; ():. PubMed ID: 39467334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhidrosis quality of life index (HidroQoL): further validation by applying classical test theory and item response theory using data from a phase III clinical trial.
    Donhauser T; Apfelbacher C; Kann G; Masur C; Kamudoni P; Salek S; Abels C; Gabes M
    J Patient Rep Outcomes; 2023 Jun; 7(1):55. PubMed ID: 37280417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development and validation of a disease-specific quality of life measure in hyperhidrosis: the Hyperhidrosis Quality of Life Index (HidroQOL©).
    Kamudoni P; Mueller B; Salek MS
    Qual Life Res; 2015 Apr; 24(4):1017-27. PubMed ID: 25367139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Internalized stigma, disease severity, quality of life, anxiety and depression in axillary hyperhidrosis.
    Gökşin Ş; İmren IG
    Ann Dermatol Venereol; 2024 Sep; 151(3):103291. PubMed ID: 39013257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials.
    Pariser DM; Hebert AA; Drew J; Quiring J; Gopalan R; Glaser DA
    Am J Clin Dermatol; 2019 Feb; 20(1):135-145. PubMed ID: 30378087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials.
    Hebert AA; Glaser DA; Green L; Werschler WP; Forsha DW; Drew J; Gopalan R; Pariser DM
    Pediatr Dermatol; 2019 Jan; 36(1):89-99. PubMed ID: 30451318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of Selective Quality of Life Analysis in Patients with Local Hyperhidrosis after Sympathicus Clipping].
    Schreiner W; Mykoliuk I; Dudek W; Sirbu H
    Zentralbl Chir; 2019 Apr; 144(2):139-145. PubMed ID: 30795027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Assessment of Facial Hyperhidrosis Management: Evaluating the Utility and Quality of Life Improvements following Botulinum Toxin Injection.
    Prodan-Barbulescu C; Castiglione L; Burtic SR; Murariu M; Reddy S; Rosca O; Bratosin F; Melania Fizedean C; Krupyshev P; Enatescu I
    Toxins (Basel); 2024 Jan; 16(1):. PubMed ID: 38276535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translating the science of quality of life into practice: What do dermatology life quality index scores mean?
    Hongbo Y; Thomas CL; Harrison MA; Salek MS; Finlay AY
    J Invest Dermatol; 2005 Oct; 125(4):659-64. PubMed ID: 16185263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COMPARATIVE ANALYSIS OF THE EFFICACIES OF BOTULINOTOXIN A THERAPY AND FRACTIONAL RADIO-FREQUENCY-LIFTING IN THE TREATMENT OF PRIMARY HYPERHYDROSIS.
    Gibradze T; Kituashvili T; Lomidze M
    Georgian Med News; 2023 Sep; (342):36-41. PubMed ID: 37991954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of generalized hyperhidrosis with oxybutynin in post-menopausal patients.
    Kim WO; Kil HK; Yoon KB; Yoo JH
    Acta Derm Venereol; 2010 May; 90(3):291-3. PubMed ID: 20526549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of botulinum toxin type A local injection therapy for head and forehead hyperhidrosis.
    Ando Y; Ohshima Y; Yanagishita T; Watanabe H; Tamada Y; Akiyama M; Watanabe D
    J Dermatol; 2022 Jul; 49(7):719-723. PubMed ID: 35393718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of quality of life in patients with primary axillary hyperhidrosis before and after suction-curettage.
    Bechara FG; Gambichler T; Bader A; Sand M; Altmeyer P; Hoffmann K
    J Am Acad Dermatol; 2007 Aug; 57(2):207-12. PubMed ID: 17368632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Hyperhidrosis: Prevalence, Severity, and Impact on Quality of Life among Jordanian Patients.
    Abusailik MA; Mustafa SMB; Alzboun HM; Al-Issa HA; Oweis SW; Alshudeifat AY; Nawaiseh MB
    Indian J Dermatol; 2021; 66(5):573. PubMed ID: 35068527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial.
    Abels C; Soeberdt M; Kilic A; Reich H; Knie U; Jourdan C; Schramm K; Heimstaedt-Muskett S; Masur C; Szeimies RM
    Br J Dermatol; 2021 Aug; 185(2):315-322. PubMed ID: 33445205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hyperhidrosis Disease Severity Measure-Axillary: Conceptualization and Development of Item Content.
    Kirsch BM; Burke L; Hobart J; Angulo D; Walker PS
    J Drugs Dermatol; 2018 Jul; 17(7):707-714. PubMed ID: 30005091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of microwave thermolysis energy levels on patient-reported outcomes for axillary hyperhidrosis and osmidrosis.
    Grove GL; Togsverd-Bo K; Schwensen JFB; Andersson NW; Nissen CV; Zachariae C; Haedersdal M
    Lasers Surg Med; 2023 Jan; 55(1):105-115. PubMed ID: 36229952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum A toxin improves life quality in severe primary focal hyperhidrosis.
    Swartling C; Naver H; Lindberg M
    Eur J Neurol; 2001 May; 8(3):247-52. PubMed ID: 11328333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.